Accretion Pharmaceuticals IPO Details
Accretion Pharmaceuticals IPO Details, GMP, Date, Subscription, Allotment
Accretion Pharmaceuticals IPO is a Book Building issue of ₹29.75 Crore, offering about 29.46 Lakh to the public.
This IPO is a complete Fresh Issue of 29.46 Lakh shares worth ₹29.75 Crore.
Accretion Pharmaceuticals IPO was subscribed 7.67 times during bidding from 14 May 2025 to 16 May 2025. Allotment was finalized on 19 May 2025, and the shares listed on NSE EMERGE on 21 May 2025.
Price band for Accretion Pharmaceuticals IPO is ₹96 to ₹101 per equity share. One lot consists of 1200 shares. Minimum investment for retail investors is ₹115200. It is recommended to apply at the cutoff price of ₹101 to improve allotment chances.
Retail investors can apply for 1 lot (1200 shares) costing ₹121200. NIIs must invest ₹242400 for 2 lots (2400 shares). QIBs need ₹1212000 to apply for 10 lots (12000 shares).
35% of the issue is reserved for retail investors, 15% for NIIs, 20% for QIBs, 30% of shares were reserved for anchor investors and their bidding date is 13 May 2025, and 5.00% of shares were reserved for Market Makers. The Market Maker for Accretion Pharmaceuticals IPO is Gretex Share Broking Private Limited.
Accretion Pharmaceuticals Limited reported revenue of ₹33.93 Crores in and ₹35.74 Crores in . It reported a Profit of ₹3.87 Crores in and a Profit of ₹0.11 Crores in after taxes.
Kfin Technologies Limited is the registrar of the Accretion Pharmaceuticals IPO. The book running lead manager is Jawa Capital Services Private Limited.
Accretion Pharmaceuticals Limited IPO (Accretion Pharmaceuticals IPO) Overview
| IPO Name | Accretion Pharmaceuticals Limited IPO |
| IPO Status | Listed on NSE at INR 79 (-21.78%) |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Face Value | ₹10 Per Equity Share |
| One Lot Size | 1200 Equity Shares |
| Total Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Fresh Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Issue Type | Book Building Issue |
| IPO Listing | NSE EMERGE |
| Retail Portion | Up to 35% of Net Issue |
| NII Portion | Up to 15% of Net Issue |
| Net QIB Portion | Up to 20% of Net Issue |
| Anchor Portion | Up to 30% of Net Issue |
| DRHP Draft Prospectus | View DRHP |
| RHP Draft Prospectus | View RHP |
| Anchor Investors List | View List |
Accretion Pharmaceuticals IPO Important Dates
The following table gives all important events and their timelines for Accretion Pharmaceuticals IPO.
| Anchor Investors Bid Date | 13 May 2025 |
| IPO Open Date | 14 May 2025 |
| IPO Close Date and Time | 16 May 2025 at 3:15 PM |
| Basis of Allotment | 19 May 2025 at 9:00 PM |
| Refunds | 20 May 2025 |
| Credit to DEMAT | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
Accretion Pharmaceuticals IPO Investor Reservation
Accretion Pharmaceuticals Limited issued a total 29.46 Lakh shares through this IPO. 12.22 Lakh (41.51%) shares reserved for Retail. 12.22 Lakh (41.51%) shares for NIIs. 1.41 Lakh (4.81%) shares for QIBs. 2.11 Lakh (7.17%) shares for Anchor Investors. 1.47 Lakh (5.01%) shares for Market Makers.
| Investor | Shares Reserved | Reservation % |
|---|---|---|
| Retail | 12,22,800 | 41.51% |
| NII | 12,22,800 | 41.51% |
| QIB | 1,41,600 | 4.81% |
| Anchor Investors | 2,11,200 | 7.17% |
| Market Makers | 1,47,600 | 5.01% |
| Total | 29,46,000 | 100% |
Accretion Pharmaceuticals IPO Lot Amounts
Investors can send applications in lots of 1200 shares and in multiples thereof. The minimum amount of retail application of 1200 shares (1 lot) is ₹121200 and maximum application amount is ₹121200 for 1200 shares (1 lots). The following depicts the minimum and maximum by Retail, HNI and QIB investors in terms of shares, lots and amounts.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 1 | ₹121200 |
| Retail Maximum | 1 | 1200 | ₹121200 |
| SHNI Minimum | 2 | 2400 | ₹242400 |
| SHNI Maximum | 4 | 4800 | ₹484800 |
| BHNI Minimum | 5 | 6000 | ₹606000 |
| BHNI Maximum | 9 | 10800 | ₹1090800 |
| QIB Minimum | 10 | 12000 | ₹1212000 |
About Accretion Pharmaceuticals Limited Company
The Accretion Pharmaceuticals Limited company was founded in year 2012, by Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati. They came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive pricing. The Company’s manufacturing facility is currently located in Ahmedabad, Sanand, Gujarat.
At present, the company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, it also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on a principle-to-principle basis with different marketers.
Accretion Pharmaceuticals Limited Financial Report and Review
| Particulars | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | Review |
|---|---|---|---|---|---|
| Revenue | 35.74 | 33.93 | 29.53 | 22.58 | Growing |
| Profit | 5.23 | 3.87 | 0.11 | 0.07 | Growing |
| Expenses | 28.56 | 28.17 | 29.39 | 22.48 | High |
| Assets | 39.98 | 27.04 | 20.57 | 17.74 | Growing |
| Networth | 13.58 | 5.34 | 3.84 | 3.07 | Growing |
| Borrowings | 13.87 | 13.48 | 8.46 | 7.78 | High |
Amount ₹ in Crores if not stated separately
Accretion Pharmaceuticals Limited Key Performance Indicators
| Particulars | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue from Operations | 33.66 | 29.38 | 22.29 |
| Revenue from Operations % | 33.66 | 29.38 | 22.29 |
| ROE % | 72.47 | 2.70 | 2.57 |
| ROCE % | 36.73 | 3.87 | 10.49 |
| EBITDA | 7.76 | 2.13 | 1.93 |
| EBITDA Margin % | 23.06 | 7.28 | 8.66 |
| PAT Margin % | 11.51 | 0.35 | 0.35 |
| Debt to Equity Ratio | 2.52 | 2.20 | 2.47 |
| Earnings Per Share (in ₹) | 9.69 | 0.26 | 0.20 |
| Return on Networth % | 72.80 | 2.70 | 2.57 |
| Net Asset Value | 13.37 | — | — |
Accretion Pharmaceuticals Limited IPO Peer Group Comparison
| No. | Company | Face Value (Rs) | EPS (Rs.) | P/E Ratio | RoNW (%) | NAV (Rs.) |
|---|---|---|---|---|---|---|
| 1 | Accretion Pharmaceuticals Limited | 10 | 8.74 | 10.98 | 38.54 | 17.09 |
| 2 | Sakar Healthcare Limited | 10 | 5.64 | 46.58 | 48.89 | 12.30 |
| 3 | Lincoln Pharmaceuticals Limited | 10 | 46.58 | 48.89 | 12.30 | |
| 4 | Sotac Pharmaceuticals Limited | 10 | 5.24 | 23.85 | 295.98 |
Objects of the Accretion Pharmaceuticals IPO Offer
Accretion Pharmaceuticals Limited filed to raise ₹29.75 Crore Rs funds through Fresh Issue and is about to use the funds on the following objects:
| S.No. | Objects of the Issue | Amt (in Cr) |
|---|---|---|
| 1 | Capital expenditure towards purchase of new equipment/machineries | 2.69 |
| 2 | Capital expenditure towards upgradation of existing manufacturing facility | 4.65 |
| 3 | Repayment/prepayment of certain borrowings availed by our Company | 1.00 |
| 4 | Funding working capital requirements | 14.68 |
| 5 | General Corporate Purpose | NA |
Amount ₹ in Crores if not stated separately
Accretion Pharmaceuticals Limited Office Address
Accretion Pharmaceuticals Limited
29 Xcelon Ind Park 1, B/h,
Intas Pharmaceuticals,
Vasna Chacharvadi,
Ahmedabad, Sanand, Gujarat,
India, 382213
Accretion Pharmaceuticals IPO Details FAQs
1. What is the Accretion Pharmaceuticals IPO ?
Accretion Pharmaceuticals IPO is a Book Building issue of ₹29.75 Crore, offering about 29.46 Lakh to the public.
2. What is the Accretion Pharmaceuticals IPO price band and face value per share?
Price band for Accretion Pharmaceuticals IPO is ₹96 to ₹101 per equity share. The face value of each share is ₹10 per equity share.
3. When will Accretion Pharmaceuticals IPO open date for subscription?
Accretion Pharmaceuticals IPO open date for subscription is 14 May 2025 and close date is 16 May 2025 at 3:15 PM.
4. What is the Accretion Pharmaceuticals IPO Investors reservation portions?
The Accretion Pharmaceuticals IPO has allocated 35% for Retail, 15% for NIIs, and 20% for QIBs. 30% of shares are reserved for Anchor Investors.
5. What is the issue size of the Accretion Pharmaceuticals IPO ?
This IPO is a complete Fresh Issue of 29.46 Lakh shares worth ₹29.75 Crore.
6. What is the lot size and the minimum investment for retail, NII, and QIB applicants of Accretion Pharmaceuticals IPO ?
In the Accretion Pharmaceuticals IPO , the minimum investment for Retail investors is 1 lot (1200 shares), totaling ₹121200. For NIIs, the investment is 2 lots (2400 shares), amounting to ₹242400. QIBs need ₹1212000 to subscribe to 10 lots (12000 shares) of the Accretion Pharmaceuticals IPO.
7. How to apply for the Accretion Pharmaceuticals IPO ?
One can apply for Accretion Pharmaceuticals IPO through the ASBA via bank account. If the application amount is below ₹5,00,000, they can apply via UPI through their stock brokers like Zerodha, Groww, Paytm Money etc.
8. What is Accretion Pharmaceuticals IPO Lot Size?
Accretion Pharmaceuticals IPO one lot size is 1200 equity shares.
9. What is the Accretion Pharmaceuticals IPO Allotment Date?
Accretion Pharmaceuticals IPO Allotment Date is 19 May 2025.
10. What is the Accretion Pharmaceuticals IPO Listing Date?
Accretion Pharmaceuticals IPO listing date is 21 May 2025.